Wegovy® is now available in the UK through controlled and limited launch

People with type 2 diabetes or prediabetes could now be prescribed Wegovy® through a controlled and limited launch.

Wegovy® was made available in the UK on Monday, September 4, 2023, Novo Nordisk has announced.

The Government is ambitious to make obesity care accessible where there is high unmet medical need.

The launch of Wegovy® will help provide an additional option to support people living with obesity in the UK and healthcare providers are now one step closer to achieving this.

It is now available in specialist NHS weight management services for people who meet the National Institute for Care and Excellence (NICE) criteria2 or privately through a registered healthcare professional.

Through the specialist NHS services, people will also receive support with diet and exercise measures to follow by a multidisciplinary team.

As supply is expected to be constrained for the foreseeable future, a proportion of available supply will be allocated for use only within the NHS to allow healthcare professionals to implement NICE guidance.

Novo Nordisk is closely monitoring Wegovy® demand and is working with regulators and providers to ensure people living with obesity can have access to and remain on treatment.